Be the new

Clinical Trial Administrator

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines

Zealand Pharma A/S (Zealand) is seeking an experienced Clinical Trial Administrator to the Clinical Operations Department. The department is responsible for setting up, overseeing and directing clinical trials from early development phases to market approval typically with the use of and collaboration with Clinical Research Organizations (CROs).

The department is part of Clinical and Medical Affairs and is composed of a dynamic team with enthusiastic and professional colleagues. We have an open and respectful working environment with great team spirit and high quality mind-set encouraging knowledge sharing and development of people and processes.

We value proactiveness and engagement in order to continue to find better solutions.

Job Profile

The successful candidate will be:

Candidate Profile

The successful candidate will have:

What we offer

Zealand’s employees are one of the company’s most important assets. We strive to attract, develop and retain the best talents, and to be a company where every employee can thrive.

At Zealand, we understand the value of a diverse workforce. As an employee, you will be part of an innovative, cross-disciplinary and cross-cultural working environment.

We offer a combined salary package including pension scheme and health insurance, as well as the option of joining the company lunch program, and use of massage, fitness and social facilities.

To find out more about working at Zealand, visit our careers site and view our company video at:


Please apply no later than November 24, 2019.

For further information, please contact Director, Clinical Operations, Gertrud K. Rasmussen

at +45 5060 3773 or

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Zealand’s portfolio also includes two clinical license collaborations with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals.

Zealand is based in Copenhagen (Søborg), Denmark. For further information about the company's business and activities, please visit or follow Zealand on LinkedIn or Twitter @ZealandPharma.